Medicare Drug Benefit May Give Marginal Boost To Sanofi’s Sales
This article was originally published in The Pink Sheet Daily
Although Plavix sales are up, the company has not seen any improvement in its other products for the elderly, Lantus and Actonel.
You may also be interested in...
In an unexpected twist, the companies offer Apotex an additional eight months of exclusivity in the proposed settlement.
FDA issued a split decision for Sanofi-Aventis' rimonabant NDAs.
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.